Scienture

SCNXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$15.444 M

$0.38 +1.99%

Close of 7 Aug 2026

Revenue

$431.6K

#3562 by revenue

Earnings

-$41.5M

Loss-making

Shares outstanding

40,630,815

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#411Optimi HealthOPTH$16.3M
#412BiofronteraBFRI$16.3M
#413ScientureSCNX$15.4M
#414VyomeHIND$15.2M
#415Tempest TherapeuticsTPST$14.6M

Where these numbers come from

Share counts and financials for Scienture are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.